{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:52:23Z","timestamp":1790949143844,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It has been established that lung cancer is the leading cause of all cancer deaths. This study sought to analyze the epidemiological trends of lung cancer over the past 30\u00a0years worldwide.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Estimates, including the global, regional, national prevalence, incidence, and years lived with disability (YLDs) of lung cancer from 1990 to 2019, were extracted from the Global Burden of Disease Study 2019 to assess the spatiotemporal dynamics in cases and age-standardized rates (ASR). The estimated annual percentage change (EAPC) was calculated to evaluate the variation in ASR. Besides, estimates of age-sex specific prevalence, decomposition analysis for incident cases, and correlation analysis of the EAPC were conducted in our study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Globally, the ASR of lung cancer prevalence, incidence and YLDs in 2019 were 38.84\/100,000 persons, 27.66\/100,000 persons, and 6.62\/100,000 persons, respectively. Over the past 30\u00a0years, the ASR of incidence (EAPC\u2009=\u2009-0.09) decreased, although that of prevalence (EAPC\u2009=\u20090.51) and YLDs (EAPC\u2009=\u20090.03) increased. The global prevalence counts was greater in males than females at all age groups and increased with age, peaking in the 65\u201369 age group for both sexes. The increase in incidence was mainly attributed to population aging. For YLDs, EAPC was negatively correlated with the human development index (<jats:italic>p<\/jats:italic>\u2009=\u20090.0008) and ASR (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) in 1990 across nation-level units.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Lung cancer remains a major public health issue globally, warranting the implementation of scientific and effective measures in different countries and territories to control it.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13281-y","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:05:41Z","timestamp":1652699141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The spatiotemporal dynamics of lung cancer: 30-year trends of epidemiology across 204 countries and territories"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"issue":"3","key":"13281_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"13281_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2012.12.007","volume":"87","author":"F Perlikos","year":"2013","unstructured":"Perlikos F, Harrington KJ, Syrigos KN. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol. 2013;87(1):1\u201311.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"13281_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.annonc.2019.10.006","volume":"31","author":"SZ Hazell","year":"2020","unstructured":"Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. 2020;31(1):96\u2013102.","journal-title":"Ann Oncol"},{"issue":"10258","key":"13281_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"issue":"10258","key":"13281_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"10258","key":"13281_CR6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2019 Demographics Collaborators","year":"2020","unstructured":"GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1160\u2013203.","journal-title":"Lancet"},{"issue":"9","key":"13281_CR7","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","volume":"9","author":"GBD 2019 Respiratory Tract Cancers Collaborators","year":"2021","unstructured":"GBD 2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med. 2021;9(9):1030\u201349.","journal-title":"Lancet Respir Med"},{"issue":"10258","key":"13281_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(20)31404-5","volume":"396","author":"GBD 2019 Viewpoint Collaborators","year":"2020","unstructured":"GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1135\u201359.","journal-title":"Lancet"},{"issue":"Supp 1","key":"13281_CR9","doi-asserted-by":"publisher","first-page":"i12","DOI":"10.1136\/injuryprev-2019-043296","volume":"26","author":"JA Haagsma","year":"2020","unstructured":"Haagsma JA, James SL, Castle CD, Dingels ZV, Fox JT, Hamilton EB, Liu Z, Lucchesi LR, Roberts N, Sylte DO, et al. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020;26(Supp 1):i12\u201326.","journal-title":"Inj Prev"},{"issue":"8","key":"13281_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study. Lancet Oncol. 2012;13(8):790\u2013801.","journal-title":"Lancet Oncol"},{"issue":"3","key":"13281_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.pan.2020.02.011","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Yi B, Liu Z, Zou H, Zhou J, Zhang Z, Xiong L, Wen Y. Global, regional and national burden of pancreatic cancer, 1990 to 2017: results from the Global Burden of Disease Study 2017. Pancreatology. 2020;20(3):462\u20139.","journal-title":"Pancreatology"},{"issue":"9","key":"13281_CR12","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.18632\/aging.202942","volume":"13","author":"B Yi","year":"2021","unstructured":"Yi B, Zeng W, Lv L, Hua P. Changing epidemiology of calcific aortic valve disease: 30-year trends of incidence, prevalence, and deaths across 204 countries and territories. Aging (Albany NY). 2021;13(9):12710\u201332.","journal-title":"Aging (Albany NY)"},{"issue":"10082","key":"13281_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","volume":"389","author":"GBD 2015 Tobacco Collaborators","year":"2017","unstructured":"GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885\u2013906.","journal-title":"Lancet"},{"issue":"2","key":"13281_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2013.284692","volume":"311","author":"M Ng","year":"2014","unstructured":"Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012. JAMA. 2014;311(2):183\u201392.","journal-title":"JAMA"},{"key":"13281_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jad.2020.03.011","volume":"268","author":"X Ren","year":"2020","unstructured":"Ren X, Yu S, Dong W, Yin P, Xu X, Zhou M. Burden of depression in China, 1990\u20132017: Findings from the global burden of disease study 2017. J Affect Disord. 2020;268:95\u2013101.","journal-title":"J Affect Disord"},{"issue":"1","key":"13281_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/thoraxjnl-2019-213722","volume":"75","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhu D, Cui B, Ding R, Shi X, He P. Association between particulate matter air pollution and lung cancer. Thorax. 2020;75(1):85\u20137.","journal-title":"Thorax"},{"key":"13281_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.envint.2015.11.007","volume":"87","author":"O Raaschou-Nielsen","year":"2016","unstructured":"Raaschou-Nielsen O, Beelen R, Wang M, Hoek G, Andersen ZJ, Hoffmann B, Stafoggia M, Samoli E, Weinmayr G, Dimakopoulou K, et al. Particulate matter air pollution components and risk for lung cancer. Environ Int. 2016;87:66\u201373.","journal-title":"Environ Int"},{"key":"13281_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","volume":"34","author":"L Stayner","year":"2013","unstructured":"Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health. 2013;34:205\u201316.","journal-title":"Annu Rev Public Health"},{"issue":"12","key":"13281_CR19","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jtho.2018.09.017","volume":"13","author":"GM Blumenthal","year":"2018","unstructured":"Blumenthal GM, Bunn PJ, Chaft JE, McCoach CE, Perez EA, Scagliotti GV, Carbone DP, Aerts H, Aisner DL, Bergh J, et al. Current status and future perspectives on neoadjuvant therapy in lung cancer. J Thorac Oncol. 2018;13(12):1818\u201331.","journal-title":"J Thorac Oncol"},{"key":"13281_CR20","doi-asserted-by":"crossref","unstructured":"Fuentes N, Silva RM, Silveyra P. Role of sex hormones in lung cancer. Exp Biol Med (Maywood). 2021;246(19):2098\u2013110.","DOI":"10.1177\/15353702211019697"},{"issue":"9","key":"13281_CR21","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/ijc.32716","volume":"146","author":"C Stapelfeld","year":"2020","unstructured":"Stapelfeld C, Dammann C, Maser E. Sex-specificity in lung cancer risk. Int J Cancer. 2020;146(9):2376\u201382.","journal-title":"Int J Cancer"},{"issue":"6","key":"13281_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1055\/s-0033-1358550","volume":"34","author":"MP Rivera","year":"2013","unstructured":"Rivera MP. Lung cancer in women: differences in epidemiology, biology, histology, and treatment outcomes. Semin Respir Crit Care Med. 2013;34(6):792\u2013801.","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"13281_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41568-021-00348-y","volume":"21","author":"S Haupt","year":"2021","unstructured":"Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer. 2021;21(6):393\u2013407.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"13281_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: How does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"13281_CR25","doi-asserted-by":"publisher","first-page":"e13174","DOI":"10.14814\/phy2.13174","volume":"5","author":"G Keramida","year":"2017","unstructured":"Keramida G, Peters AM. Fasting hepatic glucose uptake is higher in men than women. Physiol Rep. 2017;5(11):e13174.","journal-title":"Physiol Rep."},{"issue":"2","key":"13281_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression? Nat Rev Cancer. 2020;20(2):89\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"13281_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3389\/fimmu.2018.01269","volume":"9","author":"BM Gubbels","year":"2018","unstructured":"Gubbels BM, Potluri T, Fink AL, Klein SL. The confluence of sex hormones and aging on immunity. Front Immunol. 2018;9:1269.","journal-title":"Front Immunol"},{"issue":"6527","key":"13281_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1126\/science.abe7199","volume":"371","author":"T Takahashi","year":"2021","unstructured":"Takahashi T, Iwasaki A. Sex differences in immune responses. Science. 2021;371(6527):347\u20138.","journal-title":"Science"},{"issue":"7837","key":"13281_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315\u201320.","journal-title":"Nature"},{"issue":"1","key":"13281_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-018-0185-z","volume":"13","author":"H Schurz","year":"2019","unstructured":"Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Moller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2.","journal-title":"Hum Genomics"},{"issue":"5","key":"13281_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immnol. 2018;18(5):309\u201324.","journal-title":"Nat Rev Immnol"},{"issue":"10","key":"13281_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immnol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immnol"},{"issue":"10053","key":"13281_CR33","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545\u2013602.","journal-title":"Lancet"},{"issue":"10100","key":"13281_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"10159","key":"13281_CR35","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"12","key":"13281_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrc.2017.87","volume":"17","author":"AF Gazdar","year":"2017","unstructured":"Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer. 2017;17(12):725\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"13281_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535\u201346.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13281-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13281-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T08:09:02Z","timestamp":1654157342000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13281-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13281"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13281-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"27 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and informed consent were not required for this study because of public accessibility to the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"987"}}